BTN2A2, a new biomarker and therapeutic target for glioma

Heping Wang; Shanrui Pu; Haitao Xu; Lihong Yang; Lishi Shao; Xi Chen; Xiaobin Huang; Jun Pu

doi:doi:10.18632/aging.205039

← Back

Research Paper Volume 15, Issue 20 pp 10996—11011

BTN2A2, a new biomarker and therapeutic target for glioma

Figure 7. Correlation between BTN2A2 and ICI in patients with glioma. (A) Correlation between BTN2A2 and stromal, immune, and ESTIMATE scores of patients with glioma using ESTIMATE algorithm. (B–E) Correlation between BTN2A2 and ICIs in patients with glioma using the ssGSEA algorithm. (F, G) Correlation between BTN2A2 and ICI in patients with glioma using the CIBERSORT algorithm. ^*P < 0.05, ^**P < 0.01, ^***P < 0.001.